Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 70
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Osteoporos Int ; 28(4): 1271-1277, 2017 04.
Article in English | MEDLINE | ID: mdl-27942777

ABSTRACT

Rheumatoid arthritis (RA) has been associated with osteoporosis. Quantitative computed tomography (QCT) is capable of assessing bone density and composition. We found lower bone density in RA compared to controls. Age and RA duration influenced bone density. QCT may be useful to assess bone metabolism in RA. INTRODUCTION: RA is associated with generalized and periarticular osteoporosis. In addition to DXA that determines areal bone mineral density (BMD), peripheral QCT also detects volumetric BMD. QCT differentiates between total, trabecular, and cortical BMD. Here, we compared DXA and QCT in RA patients and healthy controls. METHODS: BMD of 57 female RA patients and 32 age-matched healthy female controls were assessed by DXA. QCT of the forearm ultradistal region was also performed. Densitometry data were correlated with age, disease duration, disease activity, serum CRP, and anti-CCP levels. RESULTS: Total bone density (310.4 ± 79.7 versus 354.0 ± 54.1 mg/cm3; p = 0.007) and attenuation (0.37 ± 0.05 versus 0.40 ± 0.03 1/cm; p = 0.001), trabecular density (157.6 ± 57.0 versus 193.8 ± 48.7 mg/cm3; p = 0.005) and attenuation (0.28 ± 0.03 versus 0.32 ± 0.04 1/cm; p < 0.0001), and cortical density (434.3 ± 115.8 versus 492.5 ± 64.0 mg/cm3; p = 0.006) and attenuation (0.44 ± 0.07 versus 0.47 ± 0.04 1/cm; p = 0.004) were significantly lower in RA. Both lumbar and femoral neck BMD, as well as T-scores, were significantly lower in RA versus controls (p < 0.001 in all cases). In RA, total and cortical QCT attenuation and density were associated with age, the presence of RA, and their combination. In contrast, trabecular density and attenuation were only affected by the presence of the disease but not by age. Also in RA, total trabecular and cortical density as determined by QCT significantly correlated with lumbar and/or femoral neck BMD as measured by DXA. Finally, anti-CCP seropositivity was associated with lower trabecular density and attenuation. CONCLUSIONS: Both DXA and QCT may be suitable to study bone metabolism in RA. Areal BMD determined by DXA may correlate with volumetric bone density measured by QCT. Moreover, trabecular osteoporosis may be associated by the underlying autoimmune-inflammatory disease, while cortical osteoporosis may rather be age-related.


Subject(s)
Arthritis, Rheumatoid/complications , Bone Density/physiology , Forearm/physiopathology , Osteoporosis/diagnostic imaging , Osteoporosis/etiology , Absorptiometry, Photon/methods , Adult , Age Factors , Aged , Arthritis, Rheumatoid/physiopathology , Case-Control Studies , Female , Femur Neck/diagnostic imaging , Femur Neck/physiopathology , Forearm/diagnostic imaging , Humans , Lumbar Vertebrae/diagnostic imaging , Lumbar Vertebrae/physiopathology , Middle Aged , Osteoporosis/physiopathology , Tomography, X-Ray Computed/methods , Young Adult
2.
Semergen ; 50(6): 102209, 2024 Sep.
Article in English | MEDLINE | ID: mdl-38484419

ABSTRACT

OBJECTIVE: Elder abuse, an important human rights issue and public health problem, contributes to increased disability and mortality. In the last decades, several reviews have synthesized primary studies to determine its prevalence. This umbrella review aimed to estimate the worldwide overall prevalence rate of elder abuse in the community and care setting. METHODS: Following prospective registration at PROSPERO (CRD42021281866) we conducted a search of eight electronic databases to identify systematic reviews from inception until 17 January 2023. The corrected covered area was calculated to estimate the potential overlap of primary studies between reviews. The quality of the selected reviews was assessed using a modified AMSTAR-2 instrument. We extracted data on the prevalence of any type of elder (people aged 60 years old or older) abuse in the community and care setting. RESULTS: There were 16 systematic reviews retrieved between 2007 and 2022, out of which ten captured prevalence globally, three in Iran, one in Turkey, one in China and one in Brazil. The 16 reviews included 136 primary studies in total between 1988 and 2020. The overlapping of studies between reviews was found to be moderate (5.5%). The quality of reviews was low (2, 12.5%) or critically low (14, 87.5%). The estimated range of global prevalence of overall elder abuse was wide (1.1-78%), while the estimations of specific abuse prevalence ranged from 0-81.8% for neglect, 1.1-78.9% for psychological abuse, 0.7-78.3% for financial abuse, 0.1-67.7% for physical abuse, and 0-59.2% for sexual abuse. CONCLUSIONS: Although the low quality of the evidence and the heterogeneity of the phenomenon makes it hard to give precise prevalence data, it is without a question that elder abuse is a prevalent problem with a wide dispersion. The focus of attention should shift towards interventions and policymaking to prevent this form of abuse.


Subject(s)
Elder Abuse , Humans , Elder Abuse/statistics & numerical data , Prevalence , Aged , Middle Aged , Systematic Reviews as Topic , Global Health
3.
Chemotherapy ; 58(2): 159-64, 2012.
Article in English | MEDLINE | ID: mdl-22626860

ABSTRACT

BACKGROUND: The efficacy of fluconazole (FLU), amphotericin B (AMB) and caspofungin (CAS) was tested against three Candida orthopsilosis, three C. metapsilosis and two C. parapsilosis sensu stricto isolates in neutropenic mice. METHODS: Mice were immunosuppressed by 200 mg/kg cyclophosphamide. Five-day intraperitoneal treatment was started 24 h after infection. Kidney burden was analyzed using the Kruskal-Wallis test. RESULTS: FLU 10 and 20 mg/kg as well as AMB 1 mg/kg significantly decreased the fungal burden (p < 0.05) for all eight isolates of the three species. CAS 2 and 5 mg/kg were efficacious against all C. orthopsilosis and C. metapsilosis isolates (p < 0.05), but only 5 mg/kg CAS was effective against C. parapsilosis isolates (p < 0.05). CONCLUSIONS: The efficacy of FLU and AMB against the three species was comparable. Though the activity of CAS was higher against C. orthopsilosis and C. metapsilosis, the current treatment guidelines for C. parapsilosis sensu stricto seem to be applicable to other 'psilosis' species.


Subject(s)
Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Candida/isolation & purification , Echinocandins/therapeutic use , Fluconazole/therapeutic use , Kidney/microbiology , Neutropenia/drug therapy , Amphotericin B/pharmacology , Animals , Antifungal Agents/pharmacology , Candida/drug effects , Caspofungin , Disease Models, Animal , Echinocandins/pharmacology , Female , Fluconazole/pharmacology , Immunocompromised Host , Lipopeptides , Mice , Mice, Inbred BALB C , Microbial Sensitivity Tests , Neutropenia/microbiology , Neutropenia/pathology
4.
J Cell Mol Med ; 15(8): 1688-94, 2011 Aug.
Article in English | MEDLINE | ID: mdl-20731748

ABSTRACT

Leptin is known to exert cardiodepressive effects and to induce left ventricular (LV) remodelling. Nevertheless, the autocrine and/or paracrine activities of this adipokine in the context of post-infarct dysfunction and remodelling have not yet been elucidated. Therefore, we have investigated the evolution of myocardial leptin expression following myocardial infarction (MI) and evaluated the consequences of specific cardiac leptin inhibition on subsequent LV dysfunction. Anaesthetized rats were subjected to temporary coronary occlusion. An antisense oligodesoxynucleotide (AS ODN) directed against leptin mRNA was injected intramyocardially along the border of the infarct 5 days after surgery. Cardiac morphometry and function were monitored by echocardiography over 11 weeks following MI. Production of myocardial leptin and pro-inflammatory cytokines interleukin (IL)-1ß and IL-6 were assessed by ELISA. Our results show that (1) cardiac leptin level peaks 7 days after reperfused MI; (2) intramyocardial injection of leptin-AS ODN reduces early IL-1ß and IL-6 overexpression and markedly protects contractile function. In conclusion, our findings demonstrate that cardiac leptin expression after MI could contribute to the evolution towards heart failure through autocrine and/or paracrine actions. The detrimental effect of leptin could be mediated by pro-inflammatory cytokines such as IL-1ß and IL-6. Our data could constitute the basis of new therapeutic approaches aimed to improve post-MI outcome.


Subject(s)
Leptin/metabolism , Myocardial Infarction/metabolism , Myocardium/metabolism , Ventricular Dysfunction, Left/metabolism , Animals , DNA, Antisense/administration & dosage , DNA, Antisense/genetics , Echocardiography , Enzyme-Linked Immunosorbent Assay , Heart/drug effects , Heart/physiopathology , Interleukin-1beta/metabolism , Interleukin-6/metabolism , Leptin/genetics , Male , Myocardial Infarction/physiopathology , Myocardium/pathology , Rats , Rats, Wistar , Time Factors , Ventricular Dysfunction, Left/physiopathology
5.
Phys Lett B ; 700(1): 1-6, 2011 May 30.
Article in English | MEDLINE | ID: mdl-21822351

ABSTRACT

We report on the first experimental results for microwave spectroscopy of the hyperfine structure of p¯3He+. Due to the helium nuclear spin, p¯3He+ has a more complex hyperfine structure than p¯4He+, which has already been studied before. Thus a comparison between theoretical calculations and the experimental results will provide a more stringent test of the three-body quantum electrodynamics (QED) theory. Two out of four super-super-hyperfine (SSHF) transition lines of the (n,L)=(36,34) state were observed. The measured frequencies of the individual transitions are 11.12559(14) GHz and 11.15839(18) GHz, less than 1 MHz higher than the current theoretical values, but still within their estimated errors. Although the experimental uncertainty for the difference of these frequencies is still very large as compared to that of theory, its measured value agrees with theoretical calculations. This difference is crucial to be determined because it is proportional to the magnetic moment of the antiproton.

6.
J Orthop Surg Res ; 16(1): 468, 2021 Jul 27.
Article in English | MEDLINE | ID: mdl-34315508

ABSTRACT

BACKGROUND: In painful epicondylitis, previous studies reported deficiencies in elbow proprioception. In line, proprioceptive training of the lower limb has been reported substantial beneficial in a number of indications. Therefore, we have asked if a specified proprioceptive training using training devices that are capable of activating the deep musculature in the upper limb is able to reduce the symptoms of epicondylitis. MATERIALS AND METHODS: We included 71 patients with painful lateral epicondylitis > 3 months. INTERVENTIONS: Group A: Proprioceptive training intervention with a Flexibar® (9 min daily for 12 weeks). Group B: at least 40 min running or walking/week with the XCO® in addition to the proprioceptive training with the Flexibar® (9 min daily for 12 weeks), follow-up for 12 weeks. Primary end point: Pain on visual analogue scale (VAS, 0-10); secondary end points: DASH-Score (0 = very good, 100 = very poor), grip strength according to Jamar dynamometer (kg), vibration sensation measured with a 128 Hz tuning fork. RESULTS: The pain on VAS in group A was reduced significantly. 3.6 ± 2.0 to 2.4 ± 2.1 (-33%, p = 0.013), and from 3.7 ± 2.4 to 2.2 ± 1.9 (-41%, p = 0.004) in group B after 12 weeks. There was no significant difference between A and B (p = 0.899). In both groups, there was a significant improvement of the DASH-Score (A: 32 ± 15 to 14 ± 12, -56%, p < 0.001; B: 27 ± 12 to 12 ± 11, -55%, p = 0.001) without any difference between groups A and B (p = 0.339). Grip strength improvement in group A from 24 ± 12 to 33 ± 11 kg (+38%, p < 0.001), and from 29 ± 14 to 34 ± 11 kg (+15%, p < 0.001) in group B. In line, vibration sensation improved in both groups (A: 6.3 ± 0.6 to 6.5 ± 0.5, p = 0.0001; B: 6.3 ± 0.7 to 6.6 ± 0.5, p = 0.003). CONCLUSION: A 12-week proprioceptive training with the Flexibar® improves pain, quality of life, grip strength and vibration sensation in patients with painful lateral epicondylitis. LEVEL OF EVIDENCE: Ib, randomised clinical trial TRIAL REGISTRATION: German Clinical Trials Register, DRKS00024857 , registered on 25 March 2021-retrospectively registered, http://apps.who.int/trialsearch/.


Subject(s)
Tennis Elbow , Elbow/physiology , Humans , Pain , Proprioception , Prospective Studies , Quality of Life , Tennis Elbow/therapy
7.
Phys Rev Lett ; 105(24): 243401, 2010 Dec 10.
Article in English | MEDLINE | ID: mdl-21231524

ABSTRACT

We report here the first successful synthesis of cold antihydrogen atoms employing a cusp trap, which consists of a superconducting anti-Helmholtz coil and a stack of multiple ring electrodes. This success opens a new path to make a stringent test of the CPT symmetry via high precision microwave spectroscopy of ground-state hyperfine transitions of antihydrogen atoms.

8.
Eur J Obstet Gynecol Reprod Biol ; 63(1): 65-8, 1995 Nov.
Article in English | MEDLINE | ID: mdl-8674568

ABSTRACT

We retrospectively reviewed all cases of ovarian malignancies during a 10-year period at the Department of Obstetrics and Gynecology, University Medical School of Debrecen, Hungary. The experience with 16 cases: three epithelial tumors, one granulosa cell tumor, 11 germ cell tumors (six dysgerminoma, four teratoma, one endodermal sinus tumor), and one metastatic ovarian cancer is discussed. Malignant ovarian tumors can best be treated with conservative surgery, followed by adjuvant chemotherapy. Survival mainly depends on tumor type and stage at the time of diagnosis.


Subject(s)
Ovarian Neoplasms/diagnosis , Adolescent , Chemotherapy, Adjuvant , Child , Dysgerminoma/diagnosis , Dysgerminoma/pathology , Dysgerminoma/therapy , Endodermal Sinus Tumor/diagnosis , Endodermal Sinus Tumor/pathology , Endodermal Sinus Tumor/therapy , Female , Humans , Neoplasm Metastasis , Ovarian Neoplasms/pathology , Ovarian Neoplasms/therapy , Retrospective Studies , Teratoma/diagnosis , Teratoma/pathology , Teratoma/therapy
9.
Int J Gynaecol Obstet ; 46(1): 33-7, 1994 Jul.
Article in English | MEDLINE | ID: mdl-7805981

ABSTRACT

OBJECTIVE: The existence of an aggressive form of cervical carcinoma affecting young women is studied by survival analysis of a large patient population. METHOD: Between 1969 and 1986, 1577 cases of cervical cancer were treated according to well-defined policies at the University Department of Obstetrics and Gynaecology in Debrecen, Hungary. Patients' records were reviewed to obtain data for survival analysis. Kaplan-Meier survival curves were generated for each stage and stratified for age. The log-rank test was used to compare the survival of younger and older patients at each stage. Multivariate analysis was performed to control for stage and treatment type when 5-year survival trends across four different age groups were examined. RESULTS: Comparison of survival of patients under 35 and over 35 years of age, and also those under 40 and over 40 years of age revealed no significant differences. Five-year survival across the < 30, 30-39, 40-49 and > or = 50 years age groups showed no significant trend. No differences in survival were revealed when the comparison was controlled for stage of disease and treatment type. CONCLUSION: Results suggest that cervical carcinoma in young women is not more aggressive than in other age groups.


Subject(s)
Uterine Cervical Neoplasms/mortality , Uterine Cervical Neoplasms/therapy , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Combined Modality Therapy , Female , Humans , Middle Aged , Multivariate Analysis , Neoplasm Staging , Prognosis , Retrospective Studies , Survival Analysis , Uterine Cervical Neoplasms/pathology
10.
Int J Gynaecol Obstet ; 42(1): 19-24, 1993 Jul.
Article in English | MEDLINE | ID: mdl-8103470

ABSTRACT

OBJECTIVE: To improve the treatment of cisplatin-induced acute emesis and vomiting, the adjuvant effect of two different doses of metoclopramide and metoclopramide plus droperidol was compared to a defined standard antiemetic regiment. METHOD: One-hundred and twenty-one consecutive cisplatin-based chemotherapy treatments for ovarian carcinoma were randomly assigned to receive standard plus no adjuvant (control, n = 24), high-dose metoclopramide (HDM, n = 33), very high dose metoclopramide (VHDM, n = 50) and very high dose metoclopramide plus droperidol (VHDM+DP, n = 14) antiemetic treatment. The number of vomiting episodes up to 4 h after the treatment were recorded and compared in the four different antiemetic groups. The effect of the number of previous chemotherapy cycles, the strength of previous antiemetic treatments, age and stage of disease on the number of vomiting episodes was also assessed. RESULT: The mean number of vomiting episodes during the first 4 h after the chemotherapy was 9, 6.4, 6.2 and 2.7 among patients receiving the standard HDM, VHDM and VHDM+DP antiemetic regimens, respectively. Analysis of variance of vomiting episodes confirmed significant differences between the groups (P < 0.001, F = 406.5, df = 120). The number of previous chemotherapy cycles and, to a lesser extent, the stage of disease, the strength of previous antiemetic regimens and the age showed significant correlation with the number of vomiting episodes (r = 0.443, -0.159, -0.14 and -0.009 respectively). CONCLUSION: Substantial improvement in the control of cisplating-induced vomiting can be achieved by adding high-dose metoclopramide and droperidol to a basic antiemetic regimen consisting prochlorperazine, dexamethasone and thiethylperazine.


Subject(s)
Antiemetics/therapeutic use , Cisplatin/adverse effects , Ovarian Neoplasms/drug therapy , Vomiting/drug therapy , Antiemetics/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Cisplatin/therapeutic use , Droperidol/administration & dosage , Droperidol/therapeutic use , Female , Humans , Metoclopramide/administration & dosage , Metoclopramide/therapeutic use , Middle Aged , Vomiting/chemically induced
11.
Int J Gynaecol Obstet ; 22(5): 349-55, 1984 Oct.
Article in English | MEDLINE | ID: mdl-6151918

ABSTRACT

The importance of serial ultrasonography was studied in 28 patients with histologically verified ovarian tumors. The patients were receiving combined cytostatic treatment. By graphic illustration of tumor volume, sonography can be of help in the treatment and follow-up of patients, as well as in the choice of appropriate therapy.


Subject(s)
Ovarian Neoplasms/therapy , Patient Care Planning/methods , Ultrasonography , Adolescent , Adult , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Combined Modality Therapy , Female , Follow-Up Studies , Humans , Middle Aged , Neoplasm Recurrence, Local/diagnosis , Ovarian Neoplasms/pathology , Ovarian Neoplasms/physiopathology
12.
Int J Gynaecol Obstet ; 27(2): 199-204, 1988 Oct.
Article in English | MEDLINE | ID: mdl-2903085

ABSTRACT

Forty-eight patients with FIGO stage III and IV epithelial carcinomas of the ovary were entered in this randomised trial. Radical surgery was performed and no residual tumor with a diameter greater than 2 cm was left behind. Of these patients 62.5% (10/16) had a complete or partial response on cyclophosphamide + cisplatin (CP) 87.5% (14/16) on cyclophosphamide + doxorubicin + cisplatin (CAP) and cyclophosphamide + 4'-epi-doxorubicin + cisplatin (CEP). The median time to progression was 3.5 months on CP, 12.5 months on CAP and 11.0 months on CEP. Patients treated with CAP combination chemotherapy had generally longer progression-free survival (log rank chi 2 = 5.4; P = 0.04). No significant difference was found, however, between patients on CAP and CEP. The median survival times were 12.5 months on CP, 26.5 months on CAP and 14.0 months on CEP. Patients treated with CAP combination chemotherapy had generally longer survival (logrank chi 2 = 9.08; P = 0.0099). No significant difference was found, however, between patients on CAP and CEP in terms of survival. Asymptomatic mild-to-moderate laboratory test toxicity occurred in 6-12% of patients on CP, 6-12% on CAP and no toxicity of this type and grade on CEP. Nausea and vomiting were also less severe and less frequent in the CEP group. Cardiotoxicity was seen in 12.5% (2/16) only in the CAP group.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Cystadenocarcinoma/drug therapy , Ovarian Neoplasms/drug therapy , Adult , Aged , Cisplatin/administration & dosage , Clinical Trials as Topic , Combined Modality Therapy , Cyclophosphamide/administration & dosage , Cystadenocarcinoma/mortality , Doxorubicin/administration & dosage , Epirubicin/administration & dosage , Female , Humans , Middle Aged , Ovarian Neoplasms/mortality , Random Allocation , Time Factors
13.
Eur J Gynaecol Oncol ; 16(3): 208-11, 1995.
Article in English | MEDLINE | ID: mdl-7664769

ABSTRACT

The impact of preoperative local radiotherapy on the survival of cervix carcinoma has been evaluated retrospectively in 324 Stage Ib and IIa cases treated between 1969 and 1986 at the University Department of Obstetrics and Gynaecology of Debrecen, Hungary. One hundred and ninety nine Stage Ib cases had radical hysterectomy, 132 of them following brachytherapy. Among 125 radically operated Stage IIa cases 95 had preoperative local radiotherapy. Stage-respective survival curves of patients treated by radical surgery with or without preoperative local radiotherapy were analysed by the life-table method. The use of preoperative radiotherapy was not reflected in better survival when compared to survival of patients without it. Results suggest that preoperative local radiotherapy has a limited role in the management of patients with Stage Ib and IIa cervix carcinoma.


Subject(s)
Uterine Cervical Neoplasms/radiotherapy , Uterine Cervical Neoplasms/surgery , Adolescent , Adult , Aged , Aged, 80 and over , Brachytherapy , Combined Modality Therapy , Female , Humans , Lymphatic Metastasis , Middle Aged , Neoplasm Staging , Retrospective Studies , Survival Rate , Uterine Cervical Neoplasms/mortality , Uterine Cervical Neoplasms/pathology
14.
Orv Hetil ; 138(8): 485-6, 1997 Feb 23.
Article in Hungarian | MEDLINE | ID: mdl-9139253

ABSTRACT

A case of maternal idiopathic thrombocytopenic purpura complicated by severe fetal thrombocytopenia is reported. Fetal thrombocytopenia was diagnosed by scalp blood-sampling during labour. With discussion of the relevant literature, the authors recommend the use of their method in thrombocytopenic patients in labour. In cases of fetal thrombocytopenia Caesarean section in recommended to prevent trauma and subsequent neonatal haemorrhagic complications.


Subject(s)
Fetal Diseases/diagnosis , Obstetric Labor Complications/diagnosis , Pregnancy Complications , Prenatal Diagnosis , Purpura, Thrombocytopenic, Idiopathic , Thrombocytopenia/diagnosis , Female , Humans , Infant, Newborn , Obstetric Labor Complications/etiology , Platelet Count , Pregnancy , Thrombocytopenia/blood
15.
Orv Hetil ; 139(3): 121-4, 1998 Jan 18.
Article in Hungarian | MEDLINE | ID: mdl-9467294

ABSTRACT

Tamoxifen is a non-steroidal estrogen antagonist used mainly in the adjuvant therapy of breast cancer. Tamoxifen acts primarily as an antiestrogen, but also carries estrogenic effect, mainly to the endometrium. Although diverse pathological uterine findings has been described in connection with the long term use of this drug, there is no widely accepted protocol for the monitoring of the endometrium in these patients. All patients referred for gynecologic examination at the Department of Obstetrics and Gynecology University Medical School Debrecen, Hungary with previous treatment for breast cancer were involved in a screening programme. The gradual screening programme consists of: transvaginal sonography, color doppler imaging, hysteroscopy, and endometrial curettage or sampling. If any of the first steps proved to be negative, further evaluation could be avoided. Altogether 31 patients were referred for examination and transvaginal sonography alone excluded endometrial abnormality in 9 cases, while the rest of the patients went through further evaluation. The ratio of false positive results using transvaginal sonography alone was high and could be lowered with additional color doppler imaging. Endometrial pathology could be excluded in about 50% of cases without tissue sampling. Positive histology was found in 25% of patients receiving Tamoxifen. The most frequent pathological finding was endometrial polyp. In conclusion endometrial changes found by transvaginal sonography, should be further evaluated. The gradual screening procedures enable us to the proper use of more invasive procedures.


Subject(s)
Breast Neoplasms/drug therapy , Endometrium/drug effects , Tamoxifen/therapeutic use , Adult , Aged , Endometrium/diagnostic imaging , Female , Follow-Up Studies , Humans , Hysteroscopy , Mass Screening , Middle Aged , Prospective Studies , Tamoxifen/adverse effects , Ultrasonography, Doppler, Color
16.
Magy Seb ; 54(2): 80-3, 2001 Apr.
Article in Hungarian | MEDLINE | ID: mdl-11339094

ABSTRACT

Number of bile duct injuries is rising with the spreading of laparoscopic cholecystectomy. Authors analyse the complications in the last 8 years, especially the bile duct injuries. During this period 1657 laparoscopic cholecystectomies were performed. Complication occurred in 28 cases during the intra- and postoperative period (1.68%). Main bile duct injury was detected in 7 cases (0.42%), while leakage from a Luschka's duct appeared in 10 patients. Three bleeding complications, 2 injuries of the duodenum and in 3 cases severe intraabdominal infection was observed. Four patients died (0.24%).


Subject(s)
Cholecystectomy, Laparoscopic/adverse effects , Adolescent , Adult , Aged , Aged, 80 and over , Bile , Bile Ducts/injuries , Cholecystectomy, Laparoscopic/mortality , Drainage , Duodenum/injuries , Female , Hemoperitoneum/etiology , Humans , Male , Middle Aged , Peritonitis/etiology , Retrospective Studies
17.
Nucl Instrum Methods Phys Res A ; 659(1-3): 55-60, 2011 Dec 11.
Article in English | MEDLINE | ID: mdl-22267883

ABSTRACT

The design and properties of a new cryogenic set-up for laser-microwave-laser hyperfine structure spectroscopy of antiprotonic helium - an experiment performed at the CERN-Antiproton Decelerator (AD), Geneva, Switzerland - are described. Similar experiments for (4)He have been performed at the AD for several years. Due to the usage of a liquid helium operated cryostat and therefore necessary refilling of coolants, a loss of up to 10% beamtime occurred. The decision was made to change the cooling system to a closed-circuit cryocooler. New hermetically sealed target cells with minimised (3)He gas volume and different dimensions of the microwave resonator for measuring the (3)He transitions were needed. A new set-up has been designed and tested at Stefan Meyer Institute in Vienna before being used for the 2009 and 2010 beamtimes at the AD.

18.
J Chemother ; 23(2): 107-9, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21571628

ABSTRACT

We compared the efficacy of single six mg/kg and 2x3 mg/kg caspofungin doses to the traditional one mg/kg daily against C. albicans in a neutropenic murine model. In lethality experiments, all regimens improved survival (p<0.0014 for all three isolates); differences among the treated groups were not statistically significant. We calculated kidney fungal burdens on each study day for six days postinfection using two isolates in two experiments. In the first three days, only the six mg/kg dose produced significant decrease on all study days (p<0.05-0.001), but differences between the three treatment arms disappeared by 4-6 days postinfection (p<0.05 for all isolates on all days).


Subject(s)
Antifungal Agents/therapeutic use , Candida albicans/drug effects , Candidiasis/drug therapy , Echinocandins/therapeutic use , Animals , Antifungal Agents/administration & dosage , Antifungal Agents/pharmacology , Candida albicans/isolation & purification , Candidiasis/mortality , Caspofungin , Colony Count, Microbial , Disease Models, Animal , Dose-Response Relationship, Drug , Drug Administration Schedule , Echinocandins/administration & dosage , Echinocandins/pharmacology , Female , Kidney/drug effects , Kidney/microbiology , Lipopeptides , Mice , Mice, Inbred BALB C , Neutropenia/physiopathology , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL